Mylan Institutional LLC v. Aurobindo Pharma Ltd.
Court of Appeals for the Federal Circuit
1Opinion of the Court
LOURIE, Circuit Judge.
Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., and Auromedics Phar-ma LLC (together, “Aurobindo”) appeal from a decision of the United States District Court for the Eastern District of Texas granting Mylan Institutional LLC’s (“Mylan Inst.”) and Apicore US LLC’s (“Apicore”) (together, “Mylan”) motion for a preliminary injunction precluding Auro-bindo from making, using, selling, offering to sell, and importing the accused isosulfan blue (“ISB”) product that allegedly infringes three of Apicore’s patents—U.S. Patent 7,622,992 (“the ’992 patent”), U.S. Patent 8,969,616…
2Cases cited14 opinions
- Winter v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 2008
- Graver Tank & Mfg. Co. v. Linde Air Products Co.Supreme Court of the United States · 1950
- Warner-Jenkinson Co. v. Hilton Davis Chemical Co.Supreme Court of the United States · 1997
- amazon.com, Inc. v. barnesandnoble.com, Inc. And barnesandnoble.com, LLCCourt of Appeals for the Federal Circuit · 2001
- Genentech, Inc. v. Novo Nordisk, A/s, Novo Nordisk of North America, Inc. And Novo Nordisk Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 1997
9 more not listed; retrieve them via the Exa API.
3Cited by33 opinions
- Eli Lilly and Company v. Hospira, Inc.Court of Appeals for the Federal Circuit · 2019
- Ajinomoto Co. v. Int'l Trade Comm'nCourt of Appeals for the Federal Circuit · 2019
- Ucb, Inc. v. Watson Laboratories Inc.Court of Appeals for the Federal Circuit · 2019
- Nexstep, Inc. v. Comcast Cable Communications, LLCCourt of Appeals for the Federal Circuit · 2024
- Amgen Inc. v. Amneal Pharm. LLCDistrict Court, D. Delaware · 2018
28 more not listed; retrieve them via the Exa API.